
Clinical Trial of NEO100 Recruiting Patients With Malignant Gliomas
A phase 2a clinical trial of NEO100-01 is continuing to recruit patients with malignant gliomas, with full enrollment expected in September. Six patients are left to complete the 25-patient enrollment target of the trial, according to a news release from …